United Capital Financial Advisors LLC Takes Position in DaVita Inc. $DVA

by · The Markets Daily

United Capital Financial Advisors LLC bought a new stake in DaVita Inc. (NYSE:DVA – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 6,680 shares of the company’s stock, valued at approximately $1,486,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Value Investment Professionals LLC boosted its holdings in DaVita by 2.0% in the second quarter. Value Investment Professionals LLC now owns 2,501 shares of the company’s stock valued at $556,000 after acquiring an additional 50 shares during the last quarter. Kesler Norman & Wride LLC increased its stake in DaVita by 0.8% during the first quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company’s stock worth $1,048,000 after acquiring an additional 55 shares during the last quarter. Gen Wealth Partners Inc raised its holdings in shares of DaVita by 10.0% in the 4th quarter. Gen Wealth Partners Inc now owns 880 shares of the company’s stock worth $100,000 after purchasing an additional 80 shares during the period. NewEdge Advisors LLC grew its holdings in shares of DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after purchasing an additional 88 shares during the period. Finally, Orion Porfolio Solutions LLC increased its position in DaVita by 4.4% during the 4th quarter. Orion Porfolio Solutions LLC now owns 2,360 shares of the company’s stock worth $268,000 after purchasing an additional 99 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Activity at DaVita

In related news, insider Kathleen Alyce Waters sold 15,405 shares of DaVita stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the completion of the transaction, the insider directly owned 109,194 shares in the company, valued at approximately $22,756,029.60. This trade represents a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.90% of the company’s stock.

DaVita Trading Up 1.0%

DaVita stock opened at $180.72 on Friday. DaVita Inc. has a 52 week low of $101.00 and a 52 week high of $247.49. The stock has a market cap of $11.53 billion, a P/E ratio of 14.79, a price-to-earnings-growth ratio of 0.47 and a beta of 0.88. The stock has a 50 day moving average of $211.96 and a 200-day moving average of $183.05.

DaVita (NYSE:DVA – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $4.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.88 by $0.14. DaVita had a net margin of 6.05% and a negative return on equity of 217.63%. The firm had revenue of $3.55 billion for the quarter, compared to analysts’ expectations of $3.50 billion. During the same period in the prior year, the company posted $2.95 earnings per share. The firm’s quarterly revenue was up 5.2% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities analysts predict that DaVita Inc. will post 14.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on DVA shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $265.00 price objective on shares of DaVita in a research report on Wednesday, August 5th. Oppenheimer set a $220.00 target price on shares of DaVita in a research report on Friday, August 7th. Zacks Research lowered shares of DaVita from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. TD Cowen raised shares of DaVita from a “hold” rating to a “buy” rating and lifted their price target for the stock from $201.00 to $220.00 in a research note on Friday, August 7th. Finally, Weiss Ratings raised shares of DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $221.75.

Check Out Our Latest Report on DVA

About DaVita

(Free Report)

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

See Also

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).